Article
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
Pharmacopsychiatry - 1 Nov 1999
Haffen E, Vandel P, Broly F, Vandel S, Sechter D, Bizouard P, Bechtel P R
Abstract excerpt
A pharmacokinetic interaction between the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine, was noted in a patient treated for major depression and obsessive-compulsive disorder. After the addition of citalopram, a desmethylclomipramine plasma level increase and an 8-hydroacy-desmethylclomipramine plasma level decrease were observed. The CYP2D6 phenotype, determined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
